Skip Navigation


Carcinogenesis Advance Access originally published online on February 23, 2006
Carcinogenesis 2006 27(6):1180-1186; doi:10.1093/carcin/bgi364
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/6/1180    most recent
bgi364v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pogribny, I. P.
Right arrow Articles by Karpinets, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pogribny, I. P.
Right arrow Articles by Karpinets, T. V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats

Igor P. Pogribny *, Sharon A. Ross 1, Volodymyr P. Tryndyak, Marta Pogribna, Lionel A. Poirier and Tatiana V. Karpinets 2

National Center for Toxicological Research, Jefferson, AR 72078, 1 National Cancer Institute, Bethesda, MD 20892 and 2 University of Tennessee, Knoxville, TN 37996, USA

* To whom correspondence should be addressed at: Igor P. Pogribny, Ph.D. Division of Biochemical Toxicology, NCTR, 3900 NCTR Road, Jefferson, AR 72079, USA. Tel: +870 543 7096; Fax: +870 543 7720; Email: ipogribny{at}nctr.fda.gov

The field of cancer epigenetics has received much attention in recent years. However, the relationship of cancer epigenetics with cancer etiology is not clear. Recent studies suggest the involvement of altered DNA methylation and histone modifications in the emergence of epigenetically reprogrammed cells with specific tumor-related phenotypes at premalignant stages of tumor development. In this study, we used a methyl-deficient model of rodent hepatocarcinogenesis to examine the roles of DNA, histone H3 lysine 9 and histone H4 lysine 20 methylation, and the level of the expression of Suv39h1 and Suv4-20h2 histone methyltransferases in the carcinogenic process. We demonstrated that the development of liver tumors was characterized by progressive demethylation of DNA repeats, decrease in histone H4 lysine 20 trimethylation, and a gradual decrease in the expression of Suv4-20h2 histone methyltransferase. A prominent increase in the trimethylation of histone H3 lysine 9 and in the expression of Suv39h1 histone methyltransferase was observed in preneoplastic nodules and liver tumors indicating the promotional role of these epigenetic alterations at later stages of carcinogenesis. The appearance of tumor-specific epigenetic alterations (demethylation of repetitive elements, loss of histone H4 lysine 20 trimethylation, altered expression of Suv4-20h2 and Suv39h1 histone methyltransferases) at preneoplastic stages of hepatocarcinogenesis provides experimental support for the epigenetic hypothesis of tumorigenesis that considers stress-induced epigenetic reprogramming of the cell as an important prerequisite to succeeding mutations.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
M. Esteller
Epigenetics in Cancer
N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. V. Bagnyukova, V. P. Tryndyak, B. Montgomery, M. I. Churchwell, A. R. Karpf, S. R. James, L. Muskhelishvili, F. A. Beland, and I. P. Pogribny
Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene
Carcinogenesis, March 1, 2008; 29(3): 638 - 646.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. J. Pesavento, H. Yang, N. L. Kelleher, and C. A. Mizzen
Certain and Progressive Methylation of Histone H4 at Lysine 20 during the Cell Cycle
Mol. Cell. Biol., January 1, 2008; 28(1): 468 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. A Ross and J. A Milner
Epigenetic modulation and cancer: effect of metabolic syndrome?
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 872S - 877S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
I. P. Pogribny, V. P. Tryndyak, L. Muskhelishvili, I. Rusyn, and S. A. Ross
Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis
J. Nutr., January 1, 2007; 137(1): 216S - 222S.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.